By 2033, the market for single-use bioreactors is anticipated to be worth USD 18.9 billion. By the end of 2023, the market is expected to be valued at USD 4.5 billion. It is set to experience a significant CAGR of 15.4% from 2023 to 2033.
In the review period, the market for single-use bioreactors is anticipated to have an absolute monetary opportunity of USD 14.4 billion. In 2022, it was valued at USD 3.9 billion.
Single-use bioreactors do not require the expensive and time-consuming cleaning & sterilization processes that are needed for traditional stainless-steel bioreactors. They can be more cost-effective for few biotech enterprises & research groups due to fewer personnel, maintenance, and downtime costs.
Single-use bioreactors offer additional flexibility in terms of production scale. They are easy to adapt for various batch sizes. As a result, they might make it possible for businesses to respond quickly to changes in demand or research needs.
Due to the absence of cleaning and sterilization procedures, single-use bioreactors can reduce the amount of time needed for equipment preparation. Additionally, they provide a straightforward setup, which could lead to quicker turnaround times and greater output.
Since single-use bioreactors are thrown away after use, batch contamination is less likely. This is crucial when creating sensitive items such as vaccines, biological products, and cell therapies.
Sustainability and the reduction of environmental impact are issues that the biopharmaceutical sector is growing more concerned about. Single-use bioreactors use fewer resources and emit less wastewater than traditional stainless-steel bioreactors. These characteristics are anticipated to make them a more environmentally friendly option.
Development of single-use bioreactor technology has improved performance and output quality. This development is expected to increase technology adoption in the future.
The worldwide biopharmaceutical sector has been growing steadily as more drugs are created and more biologic therapies are approved. This expansion can result in a greater need for bioreactors, particularly single-use systems.
New bioreactors have gained increased acceptance from regulatory agencies including the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) of the United States. This is explained by the advantages and security of using single-use bioreactors in manufacturing processes.
Cross-contamination between batches is unlikely as single-use bioreactors are discarded after usage. This would lessen the likelihood of batch failure caused by contamination and increase the safety of final products.
Key Takeaways from Single-use Bioreactors Market:
- The global single-use bioreactors industry grew at a steady CAGR of 16.7% in the historical period between 2018 and 2022.
- China single-use bioreactors industry is likely to create an absolute dollar opportunity of USD 3.3 billion in the review period.
- The United Kingdom single-use bioreactors industry is anticipated to top a valuation of USD 669.9 million by 2033.
- Based on product, the single-use bioreactor systems segment is anticipated to register a CAGR of 15.3% from 2023 to 2033.
- In terms of type, the stirred-tank SUB segment is expected to witness a CAGR of 15.2% in the evaluation period.
“Since no cleaning or validation procedures are required in between batches, single-use bioreactors enable quick batch changes and quick bioprocess start-ups. Biopharmaceutical firms might be able to react to changes in demand quickly owing to their flexibility. They can adjust production schedules further and address unanticipated supply chain issues.” – Says a lead analyst at Future Market Insights (FMI).
Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!
Competitive Landscape
Leading producers of single-use bioreactors might make significant investments in research & development to continuously advance their technology. They can concentrate on improving functionality, scalability, and compatibility with several cell types, enabling more effective and adaptable bioprocessing.
Key companies would frequently collaborate and develop alliances with research institutions, contract manufacturing organizations (CMOs), and biopharmaceutical businesses. These partnerships can make it easier to share technology, co-create unique solutions, and broaden product offerings to cover more uses.
For instance,
- MarqMetrix unveiled its new product, the ‘Single-use BioReactor BallProbe,’ in March 2023. Development of this novel product was motivated by the biopharmaceutical sector’s growing adoption of disposable technology. The business saw the need for solutions that might minimize risks of contamination while also boosting output and cutting costs.
Key Companies Profiled:
Applikon Biotechnology BV; Cellexus Ltd.; Celltainer Biotech B.V.; Cesco Bioengineering Co. Ltd.; Danaher Corporation
Single-use Bioreactors Market Outlook by Category:
By Product:
- Single-use Bioreactor Systems
- Single-use Media Bags
- Single-use Filtration Assemblies
- Others
By Type:
- Stirred-tank SUB
- Wave-induced Motion
- Bubble Column
- Others
By End Use:
- CROs & CMOs
- Academic & Research Institutes
- Biopharma & Pharma Companies
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
